Company intelligence / Profile preview

Radical Catheter Technologies

Campbell, California, United Statesradicalcatheter.com ↗

Ownership: Private
Development stage: Commercial

Overview

Radical Catheter Technologies has received two FDA 510(k) clearances for its novel neurovascular catheter platform (7F and 8F sizes). Clinical data from a multi-center analysis presented at the Society of NeuroInterventional Surgery showed that the catheter successfully reached target vessels in all cases evaluated. The technology is reported to offer best-in-class flexibility, stability, durability, and procedural efficiency. Initial commercial use has been positive with strong physician feedback and robust replenishment orders[1][5][8].

Therapeutic areas: CardiovascularNeurology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

NeuroTechnology Investors portfolio company; no major pharma/biotech partnerships disclosed

Beyond the preview

Go deeper on Radical Catheter Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Radical Catheter Technologies.

Explore the full profile